QLGN Company Profile and Key Details
Qualigen Therapeutics, Inc.
QLGN Stock Price Chart
Stock Price Today
Qualigen Therapeutics, Inc. (QLGN) stock declined over -0.94%, trading at $4.21 on NASDAQ, down from the previous close of $4.25. The stock opened at $4.27, fluctuating between $4.09 and $4.28 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.
Company Information
| Employees | 4 |
| Beta | 0.14 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | -0.906% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Qualigen Therapeutics, Inc. (NASDAQ: QLGN) stock price is $4.21 in the last trading session. During the trading session, QLGN stock reached the peak price of $4.28 while $4.09 was the lowest point it dropped to. The percentage change in QLGN stock occurred in the recent session was -0.94% while the dollar amount for the price change in QLGN stock was -$0.04.
The NASDAQ listed QLGN is part of Biotechnology industry that operates in the broader Healthcare sector. Qualigen Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Mr. Michael S. Poirier
Pres, Chief Operating Officer, Chief Executive Officer & Chairman
Mr. Christopher L. Lotz
Vice President of Fin. & Chief Financial Officer
Ms. Amy S. Broidrick
Pres, Chief Strategy & Operating Officer and Director
Mr. Shishir K. Sinha
Chief Operating Officer & Senior Vice President of Diagnostics
Dr. Tariq Arshad M.B.A., M.D.
Senior Vice President & Chief Medical Officer
Mr. Tariq Arshad M.B.A., M.D.
Senior Vice President & Chief Medical Officer
Dr. Wajdi Abdul-Ahad
Vice President of R&D and Chief Scientific Officer
Mr. Benedict M. Abugan
Vice President, Head of Diagnostics & Corporation Communications
QLGN's closing price is 26.2% higher than its 52-week low of $3.34 where as its distance from 52-week high of $29.45 is -85.7%.
Number of QLGN employees currently stands at 4.
Official Website of QLGN is: https://www.qualigeninc.com
QLGN could be contacted at phone 760 918 9165 and can also be accessed through its website. QLGN operates from 2042 Corte Del Nogal, Carlsbad, CA 92011, United States.
QLGN stock volume for the day was 7.06K shares. The average number of QLGN shares traded daily for last 3 months was 101.92K.
The market value of QLGN currently stands at $3.10M with its latest stock price at $4.21 and 736.43K of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com